Professional Documents
Culture Documents
" Genome Editing ": Pr. Attarca
" Genome Editing ": Pr. Attarca
" Genome Editing ": Pr. Attarca
INDUSTRIEL
“ Genome
Editing ”
Framed by :
PR. ATTARCA
By :
Souad Bousaboune N°15
Narjiss Alaoui N°06
Work plan:
Introduction
01 What do we mean by ‘genome editing’?
Moral perspectives
04 Science as a moral enterprise, Intervening in the
genome, Intervening in the genome…
Introduction :
So what do we mean by
‘genome editing’?
Timeline of genome editing
Cre-lox Bacterie
The Cre-lox editing CRISPR/Cas
technology was The CRISPR defense
successfully used for system is first
site-specific identified in
recombination in mice prokaryotes
1989 1998 2013
1992 2000
HR- mediated Zinc-finger nucleases CRISPR/Cas genome
targeting (ZFNs) editing
First study describing Discovery of zinc- First demonstration
genome editing via HR in finger proteins that that the CRISPR/Cas
mouce ES cells can target specific system can be used
DNA sequences for mammalian cell
genome editing
Introduction :
This review considers the impact of recent advances in genome
editing, which have diffused rapidly across many fields of
biological research, and the range of ethical questions to which
they give rise. It was carried out by an interdisciplinary
Working Group that included expertise in science, law,
philosophy, ethics, sociology and industry. In coming to its
conclusions, the Working Group invited contributions from a
wide range of people, including through an open call for
evidence that ran from November 2015 until February 2016.
Military applications
apk whether potentially beneficial or harmful –
raised by genome.
Biosafety
Military interest in the applications of genome Genome-edited organisms (as with all
editing may be focused on its potential for genetically modified organisms or GMOs) pose
defense purposes, for example to counteract a possible risk of harm to those handling them,
the release of a harmful substance to a and to others or to natural ecosystems if they
population. are released or escape from controlled
There is also speculative interest in the environments. there are concerns about how
possibility that genome editing may one day these can be managed outside of regulated
have a role to play in the selecting or environments, like in countries with less well-
enhancing of military personnel in relation to developed structures, and by individuals who
genetic susceptibility to disease or improved are not disciplined with regard to health
The context of genome
Patient communities
Patients, patient advocates, and families of patients with genetic disorders have diverse views
on whether germline genome editing should be used to prevent or treat genetic disorders.
Some patients suffering from conditions such as huntington disease believe strongly that it
should be used to prevent people from getting genetic diseases, especially ones that do not
currently have treatment options. Others, such as those in the deaf community, do not
consider their condition to be a disability. They worry that if human genome editing becomes
widespread, persons born with genetic conditions would be less likely to be accepted in
society. Many communities generally question the idea that eliminating genetic conditions will
improve lives, especially given that those with disabilities often report a high quality of life.
The public
The Pew Research Center, a nonpartisan group that polls the public on a variety of topics, conducted
a survey to understand the public's feelings about gene editing for newborns that would give them a
reduced risk of serious diseases during their lives. The survey noted that any change made could be
passed down to future generations, which could eventually change the genetic characteristics of the
population.Though they found some enthusiasm among the public about gene editing, they also found
that about two-thirds of U.S. adults have worries about the technology.